Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: US FDA Approves Novel Tetracyclines Nuzyra And Seysara; Hemlibra Indication Expands

Keeping Track Feature image

Related Content

Keeping Track: A Fresh Wave Of Approvals

Apr 22 2018

Keeping Track: US FDA Approvals For Tibsovo, Kisqali And Second Neupogen Biosimilar

Jul 23 2018

Keeping Track: Busy August Ends With Approval For Doravirine, CRLs For Dasotraline And Waylivra

Sep 04 2018

Keeping Track: A Burst of CRLs and BTDs, A Busy Week Of Submissions And Another Approval For Soliris

Oct 30 2017

Paratek's Omadacycline Get US Panel OK, But CABP Mortality Remains Concern

Aug 08 2018

Taiwan's ScinoPharm forges link for biosimilars production with US firm

Sep 06 2010

Roche's Hemlibra Wins Expanded FDA Approval, Opening The Door To Broad Hemophilia A Opportunity

Oct 04 2018

Pfizer Launches Nivestym At An Aggressive Discount To Other Filgrastim Products

Oct 02 2018

Keeping Track: US FDA Approves Emflaza And Parsabiv, Turns Down Opioid/Anti-Emetic Combo CL-108

Feb 13 2017

Jobs Go At Shield Therapeutics As Failed Study Fallout Hits

Feb 23 2018

Almirall Inks 'Transformational Deal' Buying Allergan's US Derma Portfolio

Aug 03 2018

Gottlieb Uses ASCO Platform To Unveil Two Pilot Programs To Speed Drug Review

Jun 03 2018

Related Companies

Paratek Pharmaceuticals, Inc.

Tetraphase Pharmaceuticals, Inc.

Achaogen, Inc.

Roche Holding AG

Amgen, Inc.

Shield Therapeutics plc

ADMA Biologics, Inc.

Clovis Oncology, Inc.

Almirall SA

Allergan plc

Genentech, Inc.

Norgine B.V.

Biotest AG

Additional Topics

United States Approvals Drug Review Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window